BR9808305A - Crystalline hydrated form, process for the preparation of hydrated crystalline form, pharmaceutical composition, process for treating a mammal, and process for treating or preventing pain. - Google Patents
Crystalline hydrated form, process for the preparation of hydrated crystalline form, pharmaceutical composition, process for treating a mammal, and process for treating or preventing pain.Info
- Publication number
- BR9808305A BR9808305A BR9808305-8A BR9808305A BR9808305A BR 9808305 A BR9808305 A BR 9808305A BR 9808305 A BR9808305 A BR 9808305A BR 9808305 A BR9808305 A BR 9808305A
- Authority
- BR
- Brazil
- Prior art keywords
- treating
- hydrated
- crystalline
- preparation
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"FORMA HIDRATADA CRISTALINA, PROCESSO PARA A PREPARAçãO DA FORMA HIDRATADA CRISTALINA, COMPOSIçãO FARMACêUTICA, PROCESSO DE TRATAMENTO DE UM MAMìFERO, E, PROCESSO DE TRATAMENTO OU DE PREVENçãO DE DOR". Uma forma cristalina hidratada de sal de sódio de composto de fórmula (I), processo para sua preparação e seu uso em terapia."CRYSTALLINE HYDRATED FORM, PROCESS FOR THE PREPARATION OF CRYSTALLINE HYDRATED FORM, PHARMACEUTICAL COMPOSITION, TREATMENT PROCESS FOR A MAMMALIAN, AND PROCESS OF TREATMENT OR PREVENTION OF PAIN". A hydrated crystalline form of the sodium salt of the compound of formula (I), process for its preparation and use in therapy.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
| PCT/EP1998/001146 WO1998039327A1 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9808305A true BR9808305A (en) | 2000-05-16 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9808305-8A BR9808305A (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated form, process for the preparation of hydrated crystalline form, pharmaceutical composition, process for treating a mammal, and process for treating or preventing pain. |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (en) |
| JP (1) | JP2001513796A (en) |
| KR (1) | KR20000075907A (en) |
| CN (1) | CN1249750A (en) |
| AP (1) | AP9901637A0 (en) |
| AR (1) | AR011178A1 (en) |
| AU (1) | AU6825198A (en) |
| BG (1) | BG103779A (en) |
| BR (1) | BR9808305A (en) |
| CA (1) | CA2282851A1 (en) |
| CO (1) | CO4940415A1 (en) |
| EA (1) | EA199900710A1 (en) |
| EE (1) | EE9900387A (en) |
| GB (1) | GB9704498D0 (en) |
| HR (1) | HRP980114A2 (en) |
| HU (1) | HUP0002109A2 (en) |
| ID (1) | ID24207A (en) |
| IL (1) | IL131489A0 (en) |
| IS (1) | IS5166A (en) |
| NO (1) | NO994303L (en) |
| NZ (1) | NZ337315A (en) |
| OA (1) | OA11154A (en) |
| PE (1) | PE51399A1 (en) |
| PL (1) | PL335652A1 (en) |
| SK (1) | SK119699A3 (en) |
| TR (1) | TR199902117T2 (en) |
| WO (1) | WO1998039327A1 (en) |
| YU (1) | YU43499A (en) |
| ZA (1) | ZA981791B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| WO2018229744A1 (en) | 2017-06-12 | 2018-12-20 | Glytech Llc. | Treatment of depression with nmda antagonists and d2/5ht2a or selective 5ht2a antagonists |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 YU YU43499A patent/YU43499A/en unknown
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Application Discontinuation
- 1998-03-03 JP JP53813598A patent/JP2001513796A/en active Pending
- 1998-03-03 CO CO98011404A patent/CO4940415A1/en unknown
- 1998-03-03 ID IDW990976A patent/ID24207A/en unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/en unknown
- 1998-03-03 IL IL13148998A patent/IL131489A0/en unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/en unknown
- 1998-03-03 AR ARP980100948A patent/AR011178A1/en unknown
- 1998-03-03 PL PL98335652A patent/PL335652A1/en unknown
- 1998-03-03 EE EEP199900387A patent/EE9900387A/en unknown
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 CN CN98803053A patent/CN1249750A/en active Pending
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/en not_active Application Discontinuation
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/en not_active Application Discontinuation
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/en unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/en unknown
- 1998-03-03 SK SK1196-99A patent/SK119699A3/en unknown
- 1998-03-03 PE PE1998000149A patent/PE51399A1/en not_active Application Discontinuation
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/en not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/en unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/en unknown
- 1999-09-03 NO NO994303A patent/NO994303L/en not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AP9901637A0 (en) | 1999-09-30 |
| AU6825198A (en) | 1998-09-22 |
| EE9900387A (en) | 2000-04-17 |
| HUP0002109A2 (en) | 2001-04-28 |
| CN1249750A (en) | 2000-04-05 |
| BG103779A (en) | 2000-06-30 |
| PE51399A1 (en) | 1999-06-07 |
| GB9704498D0 (en) | 1997-04-23 |
| CA2282851A1 (en) | 1998-09-11 |
| ID24207A (en) | 2000-07-13 |
| SK119699A3 (en) | 2000-05-16 |
| AR011178A1 (en) | 2000-08-02 |
| CO4940415A1 (en) | 2000-07-24 |
| IL131489A0 (en) | 2001-01-28 |
| KR20000075907A (en) | 2000-12-26 |
| YU43499A (en) | 2000-12-28 |
| NO994303L (en) | 1999-11-03 |
| IS5166A (en) | 1999-08-27 |
| PL335652A1 (en) | 2000-05-08 |
| WO1998039327A1 (en) | 1998-09-11 |
| OA11154A (en) | 2003-04-16 |
| HRP980114A2 (en) | 1998-12-31 |
| NO994303D0 (en) | 1999-09-03 |
| EA199900710A1 (en) | 2000-04-24 |
| ZA981791B (en) | 1999-09-03 |
| EP0966463A1 (en) | 1999-12-29 |
| TR199902117T2 (en) | 2000-03-21 |
| JP2001513796A (en) | 2001-09-04 |
| NZ337315A (en) | 2001-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO308794B1 (en) | Pharmacologically active pyridine derivatives, preparations containing the compounds and the use of the compounds | |
| TR199801180T2 (en) | New compounds with analgesic effect. | |
| CA2289717A1 (en) | Novel therapy for constipation | |
| MY123354A (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
| BR9813373A (en) | Compound, process for preparing it, pharmaceutical composition, process for preparing it, use of a compound, and, processes for effecting immunosuppression and for treating or reducing the risk of reversibly obstructive airway disease in a patient | |
| BR9814375A (en) | Inhibition of raf kinase using symmetrical and asymmetric substituted diphenyl urea | |
| BR9406363A (en) | Pharmaceutical composition process for the preparation of the same use and process for the treatment of diseases related to gastric acid | |
| PT772600E (en) | IMIDAZOLYL COMPOUNDS SUBSTITUTED IN POSTS 1 AND 2 FOR THE TREATMENT OF INFLAMMATION | |
| RU94041223A (en) | Agent for motoneuron disease treatment | |
| BG101118A (en) | Therapeutical compounds | |
| FI964772A0 (en) | (a) -annellated pyrrole derivatives and their use in pharmacy | |
| BR9714677A (en) | "3-pyridyl enantiomers and their use as analgesics" | |
| MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
| RU94020410A (en) | Method of vomiting treatment or prophylaxis in mammalian and human using the certain quinuclidine, piperidine, azanorbornane, ethylenediamine derivatives and related compounds | |
| UA41355C2 (en) | Agent for treating neuro-aids | |
| BR9813319A (en) | Compound, pharmaceutical composition for treating bacterial infections, and processes for treating bacterial infections and for preparing a compound | |
| WO1992019617A3 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
| PT1173201E (en) | METHOD FOR THE TREATMENT OF FIBROSIS USING AN ALTAGONIST OF THE ALPHA 4 SUBSTANCE OF INTEGRINA | |
| BR9607346A (en) | Compound use of a compound, pharmaceutical composition and process for the treatment of a mammal and for and preparation of compounds | |
| BR9813317A (en) | Compound, pharmaceutical composition for treating bacterial infections, and processes for treating bacterial infections, and for preparing a compound | |
| BR9814498A (en) | Process for the treatment of obesity in a human requiring such treatment, compound, use of the same, product, and pharmaceutical composition | |
| BR9808305A (en) | Crystalline hydrated form, process for the preparation of hydrated crystalline form, pharmaceutical composition, process for treating a mammal, and process for treating or preventing pain. | |
| BR9708864A (en) | Compound pharmaceutical composition and process for the treatment or prevention of a bacterial infection in a mammalian patient | |
| PT986393E (en) | USING A NITROXIDE OR ITS PRO-PHARMACY IN THE CANCER'S PROFILACTIC AND THERAPEUTIC TREATMENT | |
| BR9916043A (en) | Compound, use of the same and its pharmaceutically acceptable salts, and pharmaceutical composition for the treatment of viral herpes infections in patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |